Braze, Inc.: Form 10-Q for the period ended Jul 31, 2025
Filed with the SEC on Sep 5, 2025 and accepted by EDGAR at Sep 4, 2025, 17:39 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-07-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-05-01 to 2025-07-31 | $180.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2025-02-01 to 2025-07-31 | $342.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2025-05-01 to 2025-07-31 | $58.2m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2025-02-01 to 2025-07-31 | $109.1m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2025-05-01 to 2025-07-31 | $121.9m | us-gaap:GrossProfit |
| Gross profit | 6 months2025-02-01 to 2025-07-31 | $233.1m | us-gaap:GrossProfit |
| Research and development | 3 months2025-05-01 to 2025-07-31 | $41.3m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2025-02-01 to 2025-07-31 | $78.0m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2025-05-01 to 2025-07-31 | −$38.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2025-02-01 to 2025-07-31 | −$79.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2025-05-01 to 2025-07-31 | −$7.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2025-02-01 to 2025-07-31 | −$5.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-05-01 to 2025-07-31 | −$27.9m | us-gaap:NetIncomeLoss |
| Net income | 6 months2025-02-01 to 2025-07-31 | −$63.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-05-01 to 2025-07-31 | −$0.26 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2025-02-01 to 2025-07-31 | −$0.60 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-05-01 to 2025-07-31 | −$0.26 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2025-02-01 to 2025-07-31 | −$0.60 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-05-01 to 2025-07-31 | 106,807,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2025-02-01 to 2025-07-31 | 105,858,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2025-02-01 to 2025-07-31 | $31.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2025-02-01 to 2025-07-31 | $2.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2025-07-31 | $81.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-07-31 | $484.5m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-07-31 | $1.02bn | us-gaap:Assets |
| Current liabilities | At period end2025-07-31 | $353.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-07-31 | $423.5m | us-gaap:Liabilities |
| Shareholders' equity | At period end2025-07-31 | $598.9m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001676238-25-000134. Last ingested by Listed: Oct 29, 2026, 16:22 ET. Listed shows no prices and gives no investment advice.